GRI Bio, Inc.
GRI · NASDAQ
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $1 | $2 |
| - Cash | $4 | $5 | $3 | $5 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$2 | -$2 | -$3 |
| Revenue | $6 | $0 | $0 | – |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | – |
| % Margin | -0% | – | – | – |
| EBITDA | -$3 | -$3 | -$3 | – |
| % Margin | -53% | – | – | – |
| Net Income | -$3 | -$3 | -$3 | – |
| % Margin | -53% | – | – | – |
| EPS Diluted | -1.28 | -1.31 | -5.8 | – |
| % Growth | 2.3% | 77.4% | – | – |
| Operating Cash Flow | -$2 | -$3 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$3 | -$2 | -$2 |